|
|
US 7,473,765 B2 |
|
| Cytokine zalpha11 ligand |
| Julia E. Novak, Bainbridge Island, Wash. (US); Scott R. Presnell, Tacoma, Wash. (US); Cindy A. Sprecher, Seattle, Wash. (US); Donald C. Foster, Lake Forest Park, Wash. (US); Richard D. Holly, Seattle, Wash. (US); Jane A. Gross, Seattle, Wash. (US); Janet V. Johnston, Seattle, Wash. (US); Andrew J. Nelson, Shoreline, Wash. (US); Stacey R. Dillon, Seattle, Wash. (US); and Angela K. Hammond, Maple Valley, Wash. (US) |
| Assigned to ZymoGenetics, Inc., Seattle, Wash. (US) |
| Filed on Sep. 10, 2003, as Appl. No. 10/659,684. |
| Application 10/295723 is a division of application No. 09/923246, filed on Aug. 03, 2001, granted, now 6,605,272, filed on Aug. 12, 2003. |
| Application 09/923246 is a division of application No. 09/522217, filed on Mar. 09, 2000, granted, now 6,307,024, filed on Oct. 23, 2001. |
| Application 10/659684 is a continuation of application No. 10/295723, filed on Nov. 15, 2002, granted, now 6,686,178, filed on Feb. 03, 2004. |
| Claims priority of provisional application 60/123547, filed on Mar. 09, 1999. |
| Claims priority of provisional application 60/123904, filed on Mar. 11, 1999. |
| Claims priority of provisional application 60/142013, filed on Jul. 01, 1999. |
| Prior Publication US 2004/0110932 A1, Jun. 10, 2004 |
| This patent is subject to a terminal disclaimer. |
| Int. Cl. C07K 14/52 (2006.01); C07K 14/00 (2006.01); A61K 38/20 (2006.01); C12N 15/00 (2006.01); C07H 21/04 (2006.01)
|